InsidersTradesSigma
Track the Pharma Mar, S.A. share price and the full directors' dealings record of the company, a publicly traded company based in Spain. Shares are quoted on the ES market, under the supervision of CNMV. Operating in the Healthcare & Pharma sector, Pharma Mar, S.A. has recorded 59 public disclosures. Market capitalisation: €1.3bn. The latest transaction was filed on 17 June 2026 (Other). Among the most active insiders: MONTSERRAT ANDRADE DETRELL. All data is free.
59
Insider Decl.
n/a
Thresholds
€2m
50 ops.
Buy Volume
€6,600
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Pharma Mar, S.A. Buy (bullish), based on 9 analysts. Average price target: €104.89.
36Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,986 of 29,062 companies
68.6
score / 100
Value49
Quality89
FCF yld3.1%
Earn yld5.3%
EV/EBITDA20.8x
ROE25%
Gross mgn94%
Net mgn34%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 June 2026
Declarations59 total
100 shares@ €93.450.0006% mcap3.0% of flowShareXMADISIN ES0169501022CNMV:2026055309
122 shares@ €81.570.0006% mcap100.0% of flowShareXOFFISIN ES0169501022CNMV:2026048741
122 shares@ €81.570.0006% mcap100.0% of flowShareXOFFISIN ES0169501022CNMV:2026048744
146 shares@ €81.570.0007% mcap100.0% of flowShareXMADISIN ES0169501022CNMV:2026046976
100 shares@ €81.000.0005% mcap16.3% of flowShareXMADISIN ES0169501022CNMV:2026042671
75 shares@ €88.000.0004% mcap13.3% of flowShareXMADISIN ES0169501022CNMV:2026040871
75 shares@ €81.000.0004% mcap12.2% of flowShareXMADISIN ES0169501022CNMV:2026038713
70 shares@ €72.300.0003% mcap10.2% of flowShareXMADISIN ES0169501022CNMV:2025138818
100 shares@ €76.350.0005% mcap15.0% of flowShareXMADISIN ES0169501022CNMV:2025132590
500 shares@ €74.570.0022% mcap69.5% of flowShareXMADISIN ES0169501022CNMV:2025130674
215 shares@ €88.000.0011% mcap38.1% of flowShareXMADISIN ES0169501022CNMV:2025124295
62 shares@ €80.000.0003% mcap10.0% of flowShareXMADISIN ES0169501022CNMV:2025118883
100 shares@ €78.650.0005% mcap15.5% of flowShareXMADISIN ES0169501022CNMV:2025084231
100 shares@ €83.810.0005% mcap15.6% of flowShareXMADISIN ES0169501022CNMV:2025078458
100 shares@ €83.100.0005% mcap16.4% of flowShareXMADISIN ES0169501022CNMV:2025078461
100 shares@ €87.600.0005% mcap17.3% of flowShareXMADISIN ES0169501022CNMV:2025077199
90 shares@ €88.400.0005% mcap14.8% of flowShareXMADISIN ES0169501022CNMV:2025072593
2,402 shares@ €83.050.012% mcap100.0% of flowShareXMADISIN ES0169501022CNMV:2025072213
100 shares@ €74.200.0004% mcap14.6% of flowShareXMADISIN ES0169501022CNMV:2025068237
111 shares@ €70.750.0005% mcap5.3% of flowShareXMADISIN ES0169501022CNMV:2025047967
1,425 shares@ €69.950.0060% mcap46.4% of flowShareXMADISIN ES0169501022CNMV:2025047966
50 shares@ €82.200.0002% mcap8.1% of flowShareXMADISIN ES0169501022CNMV:2025045462
50 shares@ €88.900.0003% mcap8.8% of flowShareXMADISIN ES0169501022CNMV:2025043092
25 of 59 declarations
Acerca de Pharma Mar, S.A.
PHARMA MAR, S.A. es una empresa biofarmacéutica española centrada en la investigación y el desarrollo de tratamientos contra el cáncer. Cotiza en el mercado de valores español, XMAD.
